• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑郁发作时激活减少和亚综合征性躁狂症状预示着双相抑郁缓解率较低。

Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depression.

机构信息

1 Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.

2 Serviço de Psiquiatria, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.

出版信息

Aust N Z J Psychiatry. 2018 Oct;52(10):994-1002. doi: 10.1177/0004867417741982. Epub 2017 Nov 16.

DOI:10.1177/0004867417741982
PMID:29143534
Abstract

OBJECTIVE

Activation encompasses energy and activity and is a central feature of bipolar disorder. However, the impact of activation on treatment response of bipolar depression requires further exploration. The aims of this study were to assess the association of decreased activation and sustained remission in bipolar depression and test for factors that could affect this association.

METHODS

We assessed participants with Diagnostic and Statistical Manual of Mental Disorders (4th ed) bipolar depression ( n = 303) included in a comparative effectiveness study of lithium- and quetiapine-based treatments (the Bipolar CHOICE study). Activation was evaluated using items from the Bipolar Inventory of Symptoms Scale. The selection of these items was based on a dimension of energy and interest symptoms associated with poorer treatment response in major depression.

RESULTS

Decreased activation was associated with lower remission rates in the raw analyses and in a logistic regression model adjusted for baseline severity and subsyndromal manic symptoms (odds ratio = 0.899; p = 0.015). The manic features also predicted lower remission (odds ratio = 0.934; p < 0.001). Remission rates were similar in the two treatment groups.

CONCLUSION

Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depression. Patients with these features may require specific treatment approaches, but new studies are necessary to identify treatments that could improve outcomes in this population.

摘要

目的

激活是指能量和活动,是双相情感障碍的一个核心特征。然而,激活对双相情感障碍抑郁治疗反应的影响仍需进一步探讨。本研究旨在评估双相情感障碍抑郁患者的激活程度降低与持续缓解之间的关联,并检验可能影响这种关联的因素。

方法

我们评估了 303 名符合《精神障碍诊断与统计手册》(第 4 版)双相情感障碍抑郁诊断标准的患者,这些患者被纳入锂盐和喹硫平治疗的比较有效性研究(Bipolar CHOICE 研究)。采用双相障碍症状清单量表的项目评估激活情况。这些项目的选择基于与重度抑郁症治疗反应较差相关的能量和兴趣症状维度。

结果

在原始分析和调整基线严重程度和亚综合征性躁狂症状的逻辑回归模型中,激活程度降低与较低的缓解率相关(优势比=0.899;p=0.015)。躁狂特征也预测缓解率较低(优势比=0.934;p<0.001)。两种治疗组的缓解率相似。

结论

激活程度降低和亚综合征性躁狂症状可预测双相情感障碍抑郁的缓解率较低。具有这些特征的患者可能需要特定的治疗方法,但需要新的研究来确定可以改善该人群结局的治疗方法。

相似文献

1
Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depression.抑郁发作时激活减少和亚综合征性躁狂症状预示着双相抑郁缓解率较低。
Aust N Z J Psychiatry. 2018 Oct;52(10):994-1002. doi: 10.1177/0004867417741982. Epub 2017 Nov 16.
2
Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial.睡眠障碍可能会影响双相情感障碍的治疗效果:一项大型对照疗效试验背景下的初步研究。
J Affect Disord. 2018 Jan 1;225:563-568. doi: 10.1016/j.jad.2017.08.056. Epub 2017 Aug 19.
3
Treatment outcomes of acute bipolar depressive episode with psychosis.伴有精神病性症状的急性双相抑郁发作的治疗结局。
Depress Anxiety. 2018 May;35(5):402-410. doi: 10.1002/da.22716. Epub 2018 Jan 12.
4
IL-23 and TGF-β1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode.白细胞介素-23和转化生长因子-β1水平作为双相I型障碍伴急性躁狂发作治疗中潜在的预测生物标志物。
J Affect Disord. 2015 Mar 15;174:361-6. doi: 10.1016/j.jad.2014.12.033. Epub 2014 Dec 18.
5
Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.双相情感障碍和单相情感障碍患者临床缓解期的亚综合征抑郁症状。
J Affect Disord. 2008 Apr;107(1-3):169-74. doi: 10.1016/j.jad.2007.08.007. Epub 2007 Sep 17.
6
Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder.轨迹分析揭示 482 例双相情感障碍患者中双相抑郁症状的变化模式。
Bipolar Disord. 2019 Jun;21(4):350-360. doi: 10.1111/bdi.12715. Epub 2018 Dec 1.
7
Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale.双相障碍共病焦虑症的 CHOICE 研究:双相障碍症状清单的见解。
J Affect Disord. 2019 Mar 1;246:126-131. doi: 10.1016/j.jad.2018.12.039. Epub 2018 Dec 18.
8
Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression.鲁拉西酮与喹硫平缓释剂治疗双相抑郁障碍患者的成本效益分析
J Med Econ. 2015;18(10):821-7. doi: 10.3111/13696998.2015.1052462. Epub 2015 Jul 27.
9
Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.喹硫平治疗急性双相躁狂症:对广泛症状的疗效。
J Affect Disord. 2007;100 Suppl 1:S5-14. doi: 10.1016/j.jad.2007.02.007. Epub 2007 Mar 27.
10
Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).双相障碍的医疗负担:来自比较双相障碍有效性的临床和健康结局倡议(CHOICE 双相)研究的结果。
Bipolar Disord. 2015 Mar;17(2):212-23. doi: 10.1111/bdi.12243. Epub 2014 Aug 16.

引用本文的文献

1
New Developments in the Use of Atypical Antipsychotics in the Treatment of Bipolar Disorder: a Systematic Review of Recent Randomized Controlled Trials.新型抗精神病药在双相情感障碍治疗中的应用新进展:近期随机对照试验的系统评价。
Curr Psychiatry Rep. 2021 May 8;23(7):39. doi: 10.1007/s11920-021-01252-w.
2
Activation therapy for the treatment of inpatients with depression - protocol for a randomised control trial compared to treatment as usual.激活治疗治疗住院抑郁症患者 - 与常规治疗相比的随机对照试验方案。
BMC Psychiatry. 2019 Feb 1;19(1):52. doi: 10.1186/s12888-019-2038-2.